Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Carver

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 22, 2019
Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factorsAndrew Lee, Nasim Mavaddat, Amber N Wilcox, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 16, 2019
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factorsAndrew Lee, Nasim Mavaddat, Amber N Wilcox, et al.
Journal of Medical Genetics|November 30, 2021
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factorsAndrew Lee, Xin Yang, Jonathan Tyrer, et al.
Journal of Medical Genetics|September 26, 2022
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on <i>RAD51C</i>, <i>RAD51D</i>, <i>BARD1</i> updates to tumour pathology and cancer incidenceAndrew Lee, Nasim Mavaddat, Alex Cunningham, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2025
Correction: Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction ModelNasim Mavaddat, Lorenzo Ficorella, Tim Carver, et al.
Genome Biology|April 19, 2008
The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinantsLisa C Crossman, Virginia C Gould, J Maxwell Dow, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 17, 2023
Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction ModelNasim Mavaddat, Lorenzo Ficorella, Tim Carver, et al.
British Journal of Cancer|July 17, 2025
Adapting the BOADICEA breast and ovarian cancer risk models for the ethnically diverse UK populationLorenzo Ficorella, Xin Yang, Nasim Mavaddat, et al.
Nucleic Acids Research|November 26, 2011
GeneDB--an annotation database for pathogensFlora J Logan-Klumpler, Nishadi De Silva, Ulrike Boehme, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 22, 2019
Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factorsAndrew Lee, Nasim Mavaddat, Amber N Wilcox, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 16, 2019
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factorsAndrew Lee, Nasim Mavaddat, Amber N Wilcox, et al.
Journal of Medical Genetics|November 30, 2021
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factorsAndrew Lee, Xin Yang, Jonathan Tyrer, et al.
Journal of Medical Genetics|September 26, 2022
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on <i>RAD51C</i>, <i>RAD51D</i>, <i>BARD1</i> updates to tumour pathology and cancer incidenceAndrew Lee, Nasim Mavaddat, Alex Cunningham, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2025
Correction: Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction ModelNasim Mavaddat, Lorenzo Ficorella, Tim Carver, et al.
Genome Biology|April 19, 2008
The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinantsLisa C Crossman, Virginia C Gould, J Maxwell Dow, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 17, 2023
Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction ModelNasim Mavaddat, Lorenzo Ficorella, Tim Carver, et al.
British Journal of Cancer|July 17, 2025
Adapting the BOADICEA breast and ovarian cancer risk models for the ethnically diverse UK populationLorenzo Ficorella, Xin Yang, Nasim Mavaddat, et al.
Nucleic Acids Research|November 26, 2011
GeneDB--an annotation database for pathogensFlora J Logan-Klumpler, Nishadi De Silva, Ulrike Boehme, et al.
Pageof 4